{
    "nct_id": "NCT04572815",
    "official_title": "Randomized, Placebo-Controlled, Phase II Trial Examining Ustekinumab for Prevention of Graft Vs. Host Disease After Allogeneic Hematopoietic Cell Transplantation",
    "inclusion_criteria": "* Age 18 - 70\n* Signed informed consent.\n* Hematologic malignancy or disorder requiring allogeneic hematopoietic cell transplantation\n* Adequate vital organ function:\n\n  1. Left ventricular ejection fraction (LVEF) ≥ 50%\n  2. Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and diffusion capacity of the lung for carbon monoxide (DLCO) ≥ 50% of predicted values on pulmonary function tests\n  3. Transaminases (aspartate aminotransferase [AST], aspartate aminotransferase [ALT]) < 3 times upper limit of normal values\n  4. Creatinine clearance ≥ 50 cc/min.\n* Performance status: Karnofsky Performance Status Score ≥ 70%.\n* HCT donor is at least 8/8 (matched at HLA-A, -B, -C, -DRB1) matched with the recipient\n* PBSC (peripheral blood mobilized stem cells) as graft source\n* Fully myeloablative, reduced-toxicity ablative, or reduced-intensity conditioning regimens. If melphalan is part of the conditioning regimen, dose must be at least 75mg/m^2\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
    "exclusion_criteria": "* Active infection not controlled with appropriate antimicrobial therapy\n* Human immunodeficiency virus (HIV), hepatitis B, or hepatitis C infection\n* Anti-thymocyte globulin (ATG) as part of the conditioning regimen or GVHD prophylaxis\n* Pregnant or nursing women\n* Subjects of childbearing age unwilling to use an effective birth control method or refrain from sexual intercourse until 15 weeks after last dose of study drug\n* Non-myeloablative conditioning regimens or conditioning regimens that use less than 75mg/m^2 of melphalan\n* Prior allogeneic transplant\n* Non-malignant blood disorders (e.g. sickle cell disease, aplastic anemia)\n* Positive screening test for tuberculosis",
    "miscellaneous_criteria": ""
}